Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00496522 · ClinicalTrials.gov registry record · Phase 2
Proton Beam Therapy for Chondrosarcoma
A Phase 2 study of Chondrosarcoma, sponsored by M.D. Anderson Cancer Center.
- Active
- Registry status
- Phase 2
- Development phase
- 15
- Enrollment target
- 1
- Study location
NCT00496522: Active Phase 2 study of Chondrosarcoma, sponsored by M.D. Anderson Cancer Center.
NCT00496522 is a Phase 2 study of Chondrosarcoma that is active but no longer recruiting, run by M.D. Anderson Cancer Center. The registered enrollment target is 15 participants, below the 128-participant average among 11 other Chondrosarcoma trials with a reported enrollment target (88% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00496522, a Phase 2 study of Chondrosarcoma, is active but no longer recruiting, sponsored by M.D. Anderson Cancer Center.
- ACTIVE NOT RECRUITING
- Registry status
- Phase 2
- Development phase
- 15 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this clinical research study is to learn if proton beam therapy, with or without photon beam radiation therapy, is effective in the treatment of skull base chondrosarcoma. The safety of this treatment will also be studied.
Primary Outcome
Local recurrence defined as progression on magnetic resonance imaging (MRI) or CT if MRI is contraindicated.
Conditions Studied
Interventions
- PROCEDURE Proton Beam Therapy
Study Locations (1)
Texas
- MD Anderson Cancer Center - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15 participants |
| Start Date | 2006-04-28 |
| Est. Completion | 2026-08-19 |
| Phase | Phase 2 |
What the registry record for NCT00496522 still lists
NCT00496522 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 15 participants, a relatively small participant target, below the 128-participant average among 11 other Chondrosarcoma trials with a reported enrollment target (88% lower).
The record links to 1 condition, with Chondrosarcoma appearing as the primary indexed condition, and to 1 intervention - of which Proton Beam Therapy is the first listed.
NCT00496522 reports a single indexed study location in Texas.
Frequently Asked Questions
What is clinical trial NCT00496522 about?
NCT00496522 is a clinical study titled "Proton Beam Therapy for Chondrosarcoma". The goal of this clinical research study is to learn if proton beam therapy, with or without photon beam radiation therapy, is effective in the treatment of skull base chondrosarcoma. The safety of this treatment will also be studied.
What is the current status of trial NCT00496522?
This trial is currently active not recruiting. It is a Phase 2 study. The enrollment target is 15 participants. The study started on 2006-04-28. Estimated completion is 2026-08-19.
What conditions does trial NCT00496522 study?
This clinical trial studies the following conditions: Chondrosarcoma.
What interventions are being tested in trial NCT00496522?
The interventions under investigation include: Proton Beam Therapy (PROCEDURE).
Who is sponsoring clinical trial NCT00496522?
This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00496522 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Chondrosarcoma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00496522's enrollment target sits among peer trials
15 11th of 11 higher than 1 of 11 other Chondrosarcoma trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Chondrosarcoma trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
A Study of AdAPT-001 in Subjects With Sarcoma and Refractory Solid Tumors
RECRUITING · Phase 2
-
Abemaciclib for Bone and Soft Tissue Sarcoma With Cyclin-Dependent Kinase (CDK) Pathway Alteration
RECRUITING · Phase 2
-
AG-120 in People With IDH1 Mutant Chondrosarcoma
ACTIVE NOT RECRUITING · Phase 2
-
Therapeutic Angiotensin-(1-7) in Treating Patients With Metastatic Sarcoma That Cannot Be Removed By Surgery
COMPLETED · Phase 2
-
IACS-6274 With or Without Bevacizumab and Paclitaxel for the Treatment of Advanced Solid Tumors
RECRUITING · Phase 1
-
Assessment of Healing and Function After Reconstruction Surgery for Bone Sarcomas
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01889381 · 15 participants · Phase 2
Human Craniomaxillofacial Allotransplantation
- NCT02530073 · 15 participants · NA
Trial of Fetoscopic Endoluminal Tracheal Occlusion (FETO) for CDH
- NCT02535936 · 15 participants · NA
Cortical Plasticity in Spastic Diplegia After Selective Dorsal Rhizotomy
- NCT02918474 · 15 participants · NA
Decision Making Tool in Supporting Decision Making in Contralateral Prophylactic Mastectomy in Patients With Newly Diagnosed Breast Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI